Additional file 9 of Multi-omics integration identifies key upstream regulators of pathomechanisms in hypertrophic cardiomyopathy due to truncating MYBPC3 mutations

  • J. Pei (Contributor)
  • M. Schuldt (Contributor)
  • E. Nagyova (Contributor)
  • Z. Gu (Contributor)
  • S. El Bouhaddani (Contributor)
  • L. Yiangou (Contributor)
  • M. Jansen (Contributor)
  • J. J. A. Calis (Contributor)
  • L. M. Dorsch (Contributor)
  • C. Snijders Blok (Contributor)
  • N. A. M. Van Den Dungen (Contributor)
  • N. Lansu (Contributor)
  • B.J. Boukens (Contributor)
  • I. R. Efimov (Contributor)
  • M. Michels (Contributor)
  • M.C. Verhaar (Contributor)
  • R. de Weger (Contributor)
  • A. Vink (Contributor)
  • F. G. Van Steenbeek (Contributor)
  • A.F. Baas (Contributor)
  • R. P. Davis (Contributor)
  • H.W. Uh (Contributor)
  • D.W.D. Kuster (Contributor)
  • C Cheng (Contributor)
  • M. Mokry (Contributor)
  • J. van der Velden (Contributor)
  • F.W. Asselbergs (Contributor)
  • M. Harakalova (Contributor)



Additional file 9: Table S1 An overview of the clinical characteristics in all cardiac samples
Date made available1 Jan 2021
PublisherUnknown Publisher

Cite this